Search results
...Bristol Myers Squibb Received Updated Action Date from the U.S. Food and Drug Administration for...
FOX 23 News Albany· 3 days agoHalozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Bristol Myers Squibb was reassigned a Prescription Drug User Fee Act goal date from the
What to know about the blood test to detect colon cancer recommended by an FDA panel
ABC News· 2 hours agoA blood test to screen for colorectal cancer is one step closer to receiving approval from the U.S. ...
Ovarian cancer drug developer's stock cut in half after it files for FDA approval - Boston Business...
The Business Journals· 5 hours agoVerastem said on Friday morning that it had initiated a rolling submission of a New Drug Application...
Dog food sold by Walmart is recalled because it may contain metal pieces - WDEF
WDEF Chattanooga· 4 days agoAttention Walmart shoppers: bags of dry Pedigree-branded dog food sold by the retailer have been...
Biogen to acquire privately held Human Immunology Biosciences for $1.15 billion upfront
Market Watch· 2 days agoBiogen Inc. said Wednesday it’s acquiring privately held Human Immunology Biosciences for $1.15...
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF...
WKRN Nashville· 4 days agoCantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions ...
...TOP RANKED INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel...
Morningstar· 23 hours agoNEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Akero Therapeutics, Inc. (NASDAQ: ...
Pfizer's Hospira Recalls Select Hydrochloride Injection Carpuject Units
RTT News· 1 day agoHospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride ...
FDA lifts hold on Larimar's Friedreich's Ataxia drug study By Investing.com
Investing.com· 4 days agoLarimar Therapeutics, Inc. (NASDAQ:LRMR), a biotechnology firm engaged in developing treatments for...
FDA sets new review date for Halozyme's drug delivery tech By Investing.com
Investing.com· 3 days agoHalozyme (NASDAQ:HALO) Therapeutics, Inc. (NASDAQ: HALO) announced that the U.S. Food and Drug...